Advertisement

Johnson & Johnson to halt worldwide sales of talc-based baby powder in 2023

Click to play video: 'Lower Mainland charity providing baby supplies experiencing shortages'
Lower Mainland charity providing baby supplies experiencing shortages
A Vancouver charity supplying families in need with kits of baby supplies is experiencing concerning shortages. BabyGoRound usually receives donated items such as cribs, bassinets and clothing and gives them to lower-income families for their newborns. But as Kamil Karamali reports, the stream of donations is drying up, leaving some families without. – Aug 10, 2022

Johnson & Johnson JNJ.N will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew thousands of consumer safety lawsuits.

“As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio,” it said, adding that cornstarch-based baby powder is already sold in countries around the world.

In 2020, J&J announced that it would stop selling its talc Baby Powder in the United States and Canada because demand had fallen in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges.

The latest health and medical news emailed to you every Sunday.

The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.

Story continues below advertisement

J&J denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and asbestos-free. On Thursday, it reiterated the statement as it announced the discontinuation of the product.

The company spun off subsidiary LTL Management in October, assigned its talc claims to it and immediately placed it into bankruptcy, pausing the pending lawsuits.

Before the bankruptcy filing, the company faced costs from $3.5 billion in verdicts and settlements, including one in which 22 women were awarded a judgment of more than $2 billion, according to bankruptcy court records.

A 2018 Reuters investigation found that J&J knew for decades that asbestos, a carcinogen, was present in its talc products. Internal company records, trial testimony and other evidence showed that from at least 1971 to the early 2000s, J&J’s raw talc and finished powders sometimes tested positive for small amounts of asbestos.

In response to evidence of asbestos contamination presented in media reports, in the court room and on Capitol Hill, J&J has repeatedly said its talc products are safe, and do not cause cancer.

(Reporting by Ankur Banerjee in Bengaluru; Editing by Maju Samuel and Deepa Babington)

Sponsored content

AdChoices